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Abstract
Background: In the pulmonary circulation, there is a linear relationship between systolic pulmonary arterial pressure
(SPAP) and mean pulmonary arterial pressure (MPAP). The aim of this study was to determine the passive or active
nature of this mechanism by exploring the relationship in patients with and without autonomic rhythm control of the
heart and pulmonary circulation.
Methods: Pulmonary arterial pressure recordings from non-transplanted patients and patients with heart transplants or
double lung transplants were retrospectively reviewed. The relationships between systolic, diastolic, and mean
pulmonary arterial pressures were explored.
Results: A linear relationship was observed between the SPAP and MPAP, whether patients were paced (MPAP = 0.56
SPAP + 3.86 mmHg, r2 = 0.889), treated with inotropes (MPAP = 0.55 SPAP + 5.52 mmHg, r2 = 0.947) or pulmonary
vasodilators (MPAP = 0.58 SPAP + 2.41 mmHg, r2 = 0.927), were exercising (MPAP = 0.61 SPAP + 1.18 mmHg, r2 = 0.967),
had a heart transplant (MPAP = 0.66 SPAP +0.87 mmHg, r2 = 0.849), a double lung transplant (MPAP = 0.7 SPAP
+0.48 mmHg, r2 = 0.915), or no intervention (MPAP = 0.59 SPAP +1.75 mmHg, r2 = 0.937).
Conclusion: We demonstrate that the linear relationship between SPAP and MPAP remains in several situations.
Therefore, we conclude that the underlying mechanism is a passive consequence of the elastic properties of the
cardiopulmonary unit.
Keywords: Pulmonary circulation physiopathology, Pulmonary artery pressure, Transplantation
Background
The dynamics of the flow of blood generated by the ven-
tricle and the characteristics of the effluent arterial bed
determine the shape of the blood pressure curve. In the
systemic circulation, increased pulse pressure has long
been recognized as resulting from arterial wall stiffening
and is related to increased mortality [1, 2]. While trying
to use pulse pressure in the pulmonary circulation as a
diagnostic tool for various etiologies of pulmonary
hypertension, several investigators have identified a lin-
ear relationship between systolic (SPAP) and mean
(MPAP) pulmonary artery pressures [3–6].
Based on the work of Saouti, Stergiopulos [7, 8], and
Lankhaar [9], this observation has been explained by the
inverse relationship between resistance and compliance,
maintaining a constant product.
Though this linear dependency was seen throughout
various etiologies of pulmonary hypertension, it has not
been clearly demonstrated that the linearity is a passive
consequence of a monotonous system or an active
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mechanism adapting the stroke volume, such as a
chronotrope or vasomotor effect.
In this study, we explore the effect of autonomic affer-
ences to the heart and lungs on the SPAP/MPAP rela-
tionship by investigating patients without those
afferents; namely, lung and heart transplant patients.
The effect of rhythm control on the linearity of the rela-
tionship was also considered and patients without intrin-
sic controls such as those with atrial fibrillation or
ventricular pacing were considered to test our hypoth-
esis that the linear relationship between SPAP and
MPAP is passive and not the result of a rhythm adapta-
tion or a vasomotor autonomic reflex.
Methods
This retrospective study was approved by the Hospital
Research Ethics Board (number P2013/184), which
waived the need for patient consent for the anonymous
use of their data.
Patients were divided into three categories; non-
transplanted patients, heart transplant patients, and pul-
monary transplant patients.
Non-transplanted patients
All indwelling catheter procedures performed in the pul-
monary hypertension and heart failure clinic between
1990 and 2012 were reviewed. Patients were included
whether they had a diagnostic or follow-up procedure
(assessment of treatment efficiency or clinical deterior-
ation). Patients who had a pulmonary catheter inserted
for monitoring purposes were excluded. A total of 514
patients were included in this study.
Clinically relevant information included age and gen-
der. In the baseline group, we reviewed the charts of pa-
tients to classify them as having normal pulmonary
pressures or having pulmonary hypertension, which was
further categorized according to the World Health
Organization classification [10]. Patients without intrin-
sic rhythm control were identified by reviewing the
charts for atrial fibrillation or pacemaker implantation
and confirmed by irregular rhythm on electrocardio-
grams or by pacemaker stimulation during the pressure
measurements. We excluded 21 patients based on in-
conclusive charts. From the remaining 493 patients, we
identified 52 patients with rhythm disturbances.
According to the conditions in which the procedures
were performed, patients were divided into five sub-
categories: baseline measures, during exercise testing, or
while receiving pulmonary vasodilators, nitric oxide
(NO) inhalation, or inotropes.
When repeated measures on the same patient where
done under the same conditions, only one measure was
used to avoid statistical inference by repeated measures.
When either the systolic or diastolic value was missing,
the record was excluded.
A total of 132 measures performed at rest during in-
halation of 20 parts per million (ppm) NO were used for
analysis. Patients were divided into groups of responders
and non-responders if their MPAP diminished more
than 20 % or not according to Sitbon et al. [11].
Twenty nine measures were considered for analysis in
patients being perfused with inotropes (1, 16, 5, 1, 2, and
2 patients that were treated with 12, 10, 8, 6, 4, and
2 mg · kg · min of dobutamine, respectively; one patient
treated with 0.5 mg milrinone and one patient treated
with 10 mg · kg min enoximone).
Some right catheters were inserted and the patients
were asked to exercise. Although different workloads
were used during the same sessions, only one workload
was considered per patient. Workloads varied from 10
to 75 W.
Figure 1 represents all screening procedures distrib-
uted into the different sub-categories.
Heart transplant patients
From November 1981 to December 2012, a total of 524
heart transplants were performed in 512 patients at our
institution. All of these patients were reviewed and those
who benefitted from a right heart catheterization with
pressure measurements were included in the study.
The population was split into two categories; patients
who underwent a right heart catheterization during the
first 2 years post-transplant, and patients who were cath-
eterized after the first 2 years. This was done in order to
explore the eventual effect of cardiac re-innervation.
Eighty-three patients had 108 right heart catheterizations
performed within 2 years of heart transplantation, and
83 records were maintained in this study to prevent any
statistical inference of repeated measures. Sixty-eight pa-
tients had 106 right heart catheterizations done more
than 2 years after heart transplantation, and 68 records
were evaluated in this study.
Pulmonary transplant patients
From January 2007 to December 2012, 178 patients
underwent double lung transplantations. All of these pa-
tients were included in this study. Pressures were re-
corded by means of a Swan-Ganz catheter inserted
before the pulmonary transplant and repositioned in the
main pulmonary artery after the procedure. Measure-
ments were made 24 h after the patient reached the in-
tensive care unit to prevent any recordings that
occurred during a hemodynamically unstable period.
Two patients died within 24 h and 11 patients had their
pulmonary artery catheters retrieved or ill-positioned,
yielding unreliable right heart catheter records.
Vanden Eynden et al. Respiratory Research  (2016) 17:33 Page 2 of 10
All of the recording was done using Swan-Ganz cathe-
ters (Edwards Lifescience, Evaston, CA, USA), which
were inserted into the jugular vein using the Seldinger
technique. The tip of the catheter was positioned in the
pulmonary artery with pressure guidance or fluoroscopy
if needed. Peak systolic and end diastolic pulmonary ar-
tery pressures were measured, and mean pulmonary ar-
tery pressure was calculated using software embedded in
the measurement instruments. When more than one
measurement was made under the same conditions dur-
ing the same procedure, only the first one was taken into
account. Wedge pressure and central venous pressure
were also recorded.
Statistical analysis
Simple linear regression on each set of different mea-
surements was used to generate prediction equations re-
lating MPAP, diastolic pulmonary artery pressure
(DPAP), and SPAP; goodness of fit was assessed with R2.
Comparison of slopes and intercepts was performed
according to Armitage [12], and p < 0.05 was considered
statistically significant.
The software, MedCalc Statistical Software version
14.12.0 (MedCalc Software bvba, Ostend, Belgium;
http://www.medcalc.org; 2014)) was used for analysis.
Results
Baseline measurements in patients in sinus rhythm are
presented in Fig. 2. MPAP and SPAP were linearly re-
lated according to the following equation: MPAP = 0.59
SPAP + 1.75 mmHg (r2 = 0.937; 429 patients). MPAP and
DPAP were linearly related according to the following
equation: MPAP= 1.31 DPAP + 3.62 (r2 = 0.918; 429 pa-
tients). In Table 1, patients in the baseline group are di-
vided between those with and without (normal) pulmonary
hypertension. Patients with pulmonary hypertension were
further subdivided according to the etiology of their dis-
ease. The relationships between MPAP, SPAP, and DPAP
Fig. 1 Flowchart of catheter allocation and analysis in the non-transplanted patient group
Vanden Eynden et al. Respiratory Research  (2016) 17:33 Page 3 of 10
are presented; the differences between the coefficients of
the different slopes were not statistically significant. A lin-
ear relationship was observed between MPAP and SPAP
for patients who were not in sinus rhythm (MPAP = 0.56
SPAP + 3.86, r2 = 0.889; 52 patients), patients who under-
went double lung transplant (MPAP = 0.7, SPAP +0.48, r2
= 0.915; 165 patients), patients less than 2 years after a
heart transplantation (MPAP = 0.63 SPAP +1.43, r2 = 0.878;
83 patients), and patients more than 2 years after heart
transplant (MPAP = 0.66 SPAP + 0.87, r2 = 0.849; 68 pa-
tients; Fig. 3). Similarly, a linear relationship between
MPAP and DPAP was observed (Fig. 3).
A linear relationship was also observed when patients
were exercising (MPAP = 0.61SPAP + 1.18, r2 = 0.967;
MPAP = 1.35 DPAP +2.15, r2 = 0.950, 60 patients), when
patients were given inotropes (MPAP = 0.55 SPAP +5.52,
r2 = 0.947; MPAP = 1.37 DPAP + 1.06, r2 = 0.9, 29 pa-
tients), or when they were treated with pulmonary
Fig. 2 Linear relationship between pulse pressures in non-transplanted patients. a Linear relationship between MPAP and SPAP. b Linear relationship
between MPAP and DPAP
Table 1 Baseline group classified according to pathology
Group Number of patients MPAP SD Systolic Regression R2 Diastolic Regression R2
Normal 83 19 3.6 0.50 SPAP + 3.36 0.777 1.11DPAP + 4.00 0.976
Group 1 135 50 12,8 0.58 SPAP + 3.52 0.995 1.16DPAP + 9.68 0.995
IPAH 68 51 11,2 0.60 SPAP + 2.35 0.838 1.10DPAP + 11.6 0.878
Medication induced PAH 10 51 13,9 0.61 SPAP + 0.02 0.991 1.44DPAP+ 0.43 0.989
Cirrhosis 15 52 12,5 0.60 SPAP −0.06 0.990 1.45DPAP + 1.07 0.986
Congenital 13 57 16,8 0.61 SPAP −1.03 0.986 1.44DPAP + 1.50 0.976
Systemic sclerosis 22 44 12,5 0.61 SPAP + 1.65 0.966 1.10DPAP + 4.07 0.939
HIV 2 62 a
Hereditary 1 49 a
schistosomiasis 1 50 a
veno-occlusive disease 3 47 a
Group 2 109 38 10,8 0.59 SPAP + 3.57 0.877 1.25 DPAP + 3.25 0.867
Group 3 26 39 9,4 0.54 SPAP+ 5.62 0.908 1.31 DPAP + 1.75 0.877
Group 4 63 44 10.4 0.53 SPAP + 3.93 0.789 1.12 DPAP + 11.50 0.987
Group 5 12 44 11,04 0.53 SPAP + 6.38 0.976 1.45 DPAP-0.20 0.856
Unclassifed 1 43 a a a a a
IPAH idiopathic pulmonary arterial hypertension, MPAP mean pulmonary arterial pressure, SPAP systolic pulmonary arterial pressure, DPAP diastolic pulmonary
arterial pressure, SD standart deviation
MPAP is expressed in mmHg
awhere calculations are not applicable
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vasodilators (MPAP = 0.58 SPAP +2.41, r2 = 0.927, MPAP
= 1.31 DPAP + 5.41, r2 = 0.8660, 141 patients; Fig. 4).
In the group inhaling NO, 19 patients (14.3 %) were
identified as responders (basal MPAP = 49 ± 14 mmHg;
with 20 ppm NO: MPAP = 33 ± 11 mmHg), and 113 pa-
tients were identified as non responders (basal MPAP =
49 ± 11 mmHg; with 20 ppm NO: MPAP = 46 ±
10 mmHg). The relationship was also linear in the re-
sponder (MPAP = 0.58 SPAP +0.71, r2 = 0.895; MPAP =
1.221 DPAP = +6.013, r2 = 0.893) and non-responder
(MPAP = 0.59 SPAP = +1.97, r2 = 0.89; MPAP = 1.135
DPAP = +10.426, r2 = 0.842) groups (Fig. 4g and h).
Fig. 3 Linear relationship between MPAP and SPAP or MPAP and DPAP. a, b Non-transplanted patients who were not in sinus rhythm, c, d lung
transplant patients, e, f heart transplant patients in the first 2 years after transplantation, and g, h heart transplant patients more than 2 years
after transplantation
Vanden Eynden et al. Respiratory Research  (2016) 17:33 Page 5 of 10
The slope and intercept of the equation of every sub-
group was compared to the baseline equation of the pa-
tients in sinus rhythm (MPAP = 0.59 SPAP + 1.75). None of
the differences observed were statistically significant except
for the equation describing the relationship in patients after
double lung transplantation (MPAP = 0.7 SPAP + 0.48).
Discussion
Similar to what other studies have already shown in
smaller cohorts of patients, our study explored the linear
relationship between the SPAP and MPAP [3–6]. We
looked at the effects of various medical interventions
such as pulmonary vasodilators and inotropes and the
Fig. 4 Linear relationship between MPAP and SPAP or MPAP and DPAP. a, b In sinus rhythm at exercise; c, d while given inotropes; e, f on
pulmonary vasodilators; g, h with NO inhalation
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influence of more complex physiological inferences such
as exercise.
Our baseline measurements had coefficients of the lin-
ear regression (0.59 SPAP + 1.75) that were remarkably
similar to those identified by Chemla with high fidelity
catheters (0.61SPAP + 2). This empirical formula also is
the most accurate compared to other modalities of
evaluating MPAP [13].
This linear relationship at rest was also observed in
our study of patients treated with pulmonary vasodila-
tors or dobutamine and even the complex physiological
situation of the stress test, when there is a mixed ino-
tropic and chronotopic effect on the right ventricle and
a lusitropic effect on the left ventricle [14]. Whether or
not patients were responders to NO, a pulmonary vaso-
dilator widely used in pulmonary hypertension or acute
respiratory distress syndrome that has shown little clin-
ical benefit in clinical trials [15], had no influence on the
linear relationship (Fig. 4g and h).
The physiological implication is significant. The MPAP
is the pressure observed if the area under the pressure
curve is reduced to a rectangle, which means that the
area delimited above and below the MPAP curve have to
be equal. Through the various observations showing that
SPAP and MPAP are linearly related, we must admit that
SPAP is fixed when MPAP is defined. The area above
the MPAP curve is relatively restricted since SPAP is
fixed. Variations in the area are possible due to curve al-
terations or timing of the MPAP line crossing (Fig. 5).
The area under the MPAP curve adapts, thanks to the
DPAP values that are as a result confined in a relatively
narrow range. This scenario is valued by our observa-
tions since DPAP and MPAP are linearly related, al-
though with an r coefficient that is systematically lower
than the one observed for the SPAP/MPAP relationship.
From these geometric considerations, we can assume
that despite the multiple values of pulse pressure that
are obtainable from the classic rule of thumb (MPAP =
1/3SPAP + 2/3DPAP), only one can be physiologically
possible (Fig. 6). This means that once SPAP is defined,
pulse pressure is restricted to narrow values and would
be of low diagnostic value in order to discriminate be-
tween various forms of pulmonary arterial hypertension.
However, some caution is warranted concerning this
theoretical reasoning since some authors have success-
fully relied on the pulse pressure for more elaborate
Fig. 5 Geometric limitation of the DPAP. Four fictive pulmonary pressure waves are illustrated sharing the same MPAP and SPAP. For a given
period, if the MPAP are equal, then the areas a, b, c, and d are the same in all cases. The area B, SPAP, E and E, DPAP, and C have to be equal.
Changing the area of A,SPAP, and E is geometrically limited and include the possible values of DPAP
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purposes such as partitioning the resistance in chronic
thromboembolic disease [16, 17], while others have
failed to do so [18].
This remarkable property of the pulmonary circula-
tion, which is quite different from its systemic counter-
part, may have different explanations. The question
remains whether its nature is active or passive. One
might postulate that an autonomic feedback control af-
fects the resistance of the pulmonary tree, inotropic
properties of the right ventricle, and the cardiac rhythm
in order to maintain the pulse pressure in its defined
value around the MPAP. If this hypothesis were true, the
linear relationship between MPAP and SPAP would dis-
appear when the rate control disappears, such as in pa-
tients with atrial fibrillation or artificially paced hearts.
This was not observed in our patients; the linear coeffi-
cient was quite consistent with the empirical formula
(0.56SPAP + 3.86). Moreover, the crosstalk between the
pulmonary circulation and the right heart is also not me-
diated through autonomic innervation of the heart, be-
cause the de-innervated transplanted hearts produced a
similar pulse pressure pattern (0.63 SPAP + 1.43).
When the right heart is pumping blood to freshly
transplanted lungs, the relationship is a little different.
The pulse pressure is narrowed because not only does
the SPAP tend to incline towards the MPAP (0.7SPAP +
0.48), but so does the DPAP (1.16DPAP + 3.58). Notably,
the linear relationship stands despite the absence of re-
sidual autonomic afferents to the lungs, while only the
coefficients are different. Therefore, three hypotheses
should be investigated in the future. First, the discrep-
ancy in the coefficient could be explained by the inher-
ent imprecision of the fluid-filled catheters. Second,
pressures are recorded at the tip of the catheter that lies
in the pulmonary artery distal to the pulmonary anasto-
mosis, wherein the elastic wall discontinuity may
dampen the pressure wave. Finally, the concomitant
change in pulmonary resistance and compliance caused
by the lung transplantation could induce the deviation.
Those changes are related to the structural changes in-
troduced in the system by the new lungs and by the
interruption of nervous afferents to the transplanted
organs.
From the previous observations, we can postulate that
the linear relationship between the MPAP and SPAP
seems to be a monotonous phenomenon independent of
any active control, which has been suggested by other
authors emphasizing that the relationship is observed ir-
respective of the patient’s age, sex, heart rate, cardiac
output, or pulmonary wedge pressure [5, 6], but it has
not been reported in transplanted patients.
The pulmonary circulation serves a different purpose
than the systemic circulation. The latter distributes
blood to some vascular beds while shutting off others,
whereas the pulmonary circulation tries to ensure an
evenly distributed flow matching the ventilation areas.
Therefore, its compliant compartment extends far into
the periphery [19] and the already low basal resistance
even decreases during exercise. The relationship be-
tween resistance and compliance has been postulated to
be inversely related, and the product of both parameters
(RC). This is because the time constant of the exponen-
tial decay function portraying the diastolic portion of the
pulmonary pressure curve is considered constant. The
constancy of RC has been shown in healthy patients [20]
and those with diseased conditions [9], and even in sin-
gle lung ventilation in the setting of thromboembolic
hypertension [8]. The hyperbolic relationship between
pulmonary vascular resistance and arterial compliance
has been advocated as the reason for the proportional
relationship between SPAP and MPAP [21]. The prob-
lem with computing values based on compliance is that
Fig. 6 Theoretical and effective values of the pulse pressure. All possible values for SPAP and DPAP allowed by the rule of thumb are represented
along the line in (a), although only one pair would be physiologically observed as illustrated in (b)
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it is far from obvious to correctly measure compliance
[22]. Moreover, to our best knowledge all clinical studies
done using the RC quotient have recorded compliance
as the ratio of stroke volume over pulse pressure, which
overestimates compliance compared to one done with
the more sophisticated pulse pressure method [23].
Compliance could be extracted from the diastolic part of
the cardiac cycle [24], but the diastolic portion of the
pressure curve is bi-exponential rather than mono-
exponential [25], and measurements based on the dia-
stolic decay of the pressure curve should be more accur-
ate for identifying various inflexion points. Therefore,
extracting compliance via curve fitting requires tech-
niques that provide better performance than fluid-filled
catheters [26]. These technical and physiological consid-
erations might explain why some authors have found
discrepancies in calculating the RC constant despite a
constant SPAP/MPAP ratio in different pathological
states [27]. Aware of these technical pitfalls, we pre-
ferred not to elaborate on the RC time constant and in-
stead to witness the passive phenomenon of pulse
pressure confinement.
Limitations
The main limitations of this study are due to its retro-
spective design and the heterogeneity of the settings in
which the measurements were made. Lung transplant
patients were measured in the intensive care unit, heart
transplant patients in the cath-lab, and the other patients
in the coronary care unit. Another limitation is that all
measurements were made with fluid-filled catheters,
which are commonly prone to a damping phenomenon,
and they yield less accurate readings in comparison with
high fidelity catheters. We tried to overcome these short-
comings by including a large number of patients, espe-
cially in the transplanted cohort.
Conclusion
The linear proportionality between MPAP and SPAP in
the pulmonary circulation has been reported exten-
sively in both healthy and disease states. Such observa-
tions were further investigated in conditions yielding
diverse physiological challenges including administra-
tion of inotropes or pulmonary vasodilators, or during
exercise. The proportionality was preserved despite dis-
turbances of the native cardiac rhythm or autonomic
inference, suggesting the passive nature of the predis-
posing mechanism.
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